Insider Stock Trading History of Valentino Michael J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Valentino Michael J since year 2005. The trader's CIK number is 1319551. At the time of this reporting, Valentino Michael J is the Executive Chairman of Dipexium Pharmaceuticals, Inc. . (stock ticker symbol DPRX). See this page for all insider trading activities at Dipexium Pharmaceuticals, Inc. .

Note that in the past Valentino Michael J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Valentino Michael J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-06-14 PLXP Dipexium Pharmaceuticals, Inc. Buy 29,091 6.88 200,000
2008-01-02 ARXT Adams Respiratory Therapeutics, Inc. Option Ex 70,000 .40 28,000
2008-01-02 ARXT Adams Respiratory Therapeutics, Inc. Sale 70,000 59.67 4,177,250
2007-10-05 ARXT Adams Respiratory Therapeutics, Inc. Option Ex 35,000 .40 14,000
2007-10-05 ARXT Adams Respiratory Therapeutics, Inc. Sale 35,000 40.00 1,400,000
2007-10-01 ARXT Adams Respiratory Therapeutics, Inc. Sale 1,409 38.56 54,331
2007-10-01 ARXT Adams Respiratory Therapeutics, Inc. Sale 17,891 38.26 684,581
2007-10-01 ARXT Adams Respiratory Therapeutics, Inc. Sale 15,700 37.70 591,890
2007-10-01 ARXT Adams Respiratory Therapeutics, Inc. Option Ex 35,000 .40 14,000
2007-07-03 ARXT Adams Respiratory Therapeutics, Inc. Sale 35,000 40.13 1,404,480
2007-07-02 ARXT Adams Respiratory Therapeutics, Inc. Sale 1,600 39.25 62,800
2007-07-03 ARXT Adams Respiratory Therapeutics, Inc. Option Ex 35,000 .40 14,000
2007-07-02 ARXT Adams Respiratory Therapeutics, Inc. Sale 33,400 39.41 1,316,360
2007-07-02 ARXT Adams Respiratory Therapeutics, Inc. Option Ex 35,000 .40 14,000
2007-05-21 ARXT Adams Respiratory Therapeutics, Inc. Option Ex 35,000 .40 14,000
2007-05-21 ARXT Adams Respiratory Therapeutics, Inc. Sale 35,000 40.00 1,400,000
2007-01-03 ARXT Adams Respiratory Therapeutics, Inc. Option Ex 70,000 .40 28,000
2007-01-03 ARXT Adams Respiratory Therapeutics, Inc. Sale 68,200 41.37 2,821,706
2007-01-03 ARXT Adams Respiratory Therapeutics, Inc. Sale 1,800 41.76 75,171
2006-10-12 ARXT Adams Respiratory Therapeutics, Inc. Option Ex 19,300 .40 7,720
2006-10-13 ARXT Adams Respiratory Therapeutics, Inc. Option Ex 15,700 .40 6,280
2006-10-12 ARXT Adams Respiratory Therapeutics, Inc. Sale 19,300 40.00 772,000
2006-10-13 ARXT Adams Respiratory Therapeutics, Inc. Sale 15,700 40.00 628,000
2006-10-02 ARXT Adams Respiratory Therapeutics, Inc. Sale 200 35.25 7,050
2006-10-02 ARXT Adams Respiratory Therapeutics, Inc. Sale 11,401 35.91 409,444
2006-10-02 ARXT Adams Respiratory Therapeutics, Inc. Sale 23,399 35.46 829,751
2006-10-02 ARXT Adams Respiratory Therapeutics, Inc. Option Ex 35,000 .40 14,000
2006-07-03 ARXT Adams Respiratory Therapeutics, Inc. Option Ex 16,600 .40 6,640
2006-07-06 ARXT Adams Respiratory Therapeutics, Inc. Sale 13,400 43.15 578,210
2006-07-05 ARXT Adams Respiratory Therapeutics, Inc. Sale 40,000 43.26 1,730,400
2006-07-06 ARXT Adams Respiratory Therapeutics, Inc. Option Ex 13,400 .40 5,360
2006-07-05 ARXT Adams Respiratory Therapeutics, Inc. Option Ex 40,000 .40 16,000
2006-07-03 ARXT Adams Respiratory Therapeutics, Inc. Sale 16,600 44.09 731,894
2006-04-03 ARXT Adams Respiratory Therapeutics, Inc. Option Ex 53,227 .40 21,290
2006-04-04 ARXT Adams Respiratory Therapeutics, Inc. Option Ex 8,628 .40 3,451
2006-04-03 ARXT Adams Respiratory Therapeutics, Inc. Sale 53,227 39.66 2,110,982
2006-04-05 ARXT Adams Respiratory Therapeutics, Inc. Option Ex 8,145 .40 3,258
2006-04-04 ARXT Adams Respiratory Therapeutics, Inc. Sale 8,628 40.00 345,120
2006-04-05 ARXT Adams Respiratory Therapeutics, Inc. Sale 8,145 40.00 325,800

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Valentino Michael J (Executive Chairman of Dipexium Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.